David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

When it comes to biotech stocks, some investors like to swing for the fences. When that plan works, it feels great. Shareholders of Dendreon (Nasdaq: DNDN), for example, saw their investment rise from $3 in March 2009 to more than $20 in just two months. The stock has doubled again… Read More

In 1999, James Glassman and Kevin Hassett grabbed headlines with their book Dow 36,000: The New Strategy for Profiting From the Coming Rise in the Stock Market. Their timing was impeccably bad. The Dow Jones Industrial Average peaked later that year at 11,900 and didn’t see the same levels again… Read More

If you want to gauge the current interest in initial public offerings (IPOs), then you simply need to look at the stock chart of social media firm LinkedIn (Nasdaq: LNKD). Right now, its stock is scorching hot, as investors seek out business models that possess robust growth prospects. Judging… Read More

Momentum investing can lead to powerful gains. That’s why some investors suggest you should always “let your winners ride,” presumably to even higher prices. This was my logic when I recommended shares of Crocs (Nasdaq: CROX) last August.   The footwear… Read More